Pakos, Julian
Asché, Laura
Popova, Anna
Heine, Carl
Sanchez, Dario
Aslan, Behrem
Selaskowski, Benjamin
Fuchs, Madita
Ettinger, Ulrich
Philipsen, Alexandra
Braun, Niclas
Wiebe, Annika
Funding for this research was provided by:
Universitätsklinikum Bonn
Article History
Received: 19 March 2025
Accepted: 15 September 2025
First Online: 3 October 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki as revised in 2013 and approved by the Ethics Committee of the Faculty of Medicine at the University of Bonn (protocol number: 362/22). All participants gave written informed consent.
: Not applicable.
: NB and AP receive funding over the Nordrhein-Westfalen (NRW) network iBehave, by which JP’s and LA’s PhD positions are funded. AP and NB received funding by MEDICE Arzneimittel Pütter GmbH & Co KG, by which AW’s PhD position was funded. NB received funding by BONFOR, by which NB and BS were partly funded. AP received fundings by the German Federal Ministry of Education and Research by which BS’s PhD position was partly funded. AP has received further funding by the German Federal Ministry of Education and Research, Horizon2020, and DFG, North Rhine Westphalia, and Medice Arzneimittel Pütter GmbH & Co KG; she has been on advisory boards for Takeda, Medice, and Boehringer; and delivered lectures sponsored by Medice, Takeda. JP received compensation by Medice Arzneimittel Pütter GmbH & Co KG for conducting a workshop. All other authors declare no conflicts of interest.